Table 1.
Characteristic | Total | Negative for antibodies (IgG and IgM) | Positive for antibodies (IgG or IgM) | ||||
---|---|---|---|---|---|---|---|
Total | 474 | 394 | 83.1% | 80 | 16.9% | (13.6%, 20.6%) | |
Sex—no. (%) | |||||||
Male | 182 | 38.4% | 156 | 85.7% | 26 | 14.3% | (9.6%, 20.2%) |
Female | 292 | 61.6% | 238 | 81.5% | 54 | 18.5% | (14.2%, 23.4%) |
Age—mean (Std) | 42.0 | 11.30 | 41.9 | 11.3 | 42.4 | 11.5 | N/A |
Race—no. (%) | |||||||
Non-Hispanic White | 339 | 71.5% | 286 | 84.4% | 53 | 15.6% | (11.9%, 20.0%) |
Hispanic or Latino | 31 | 6.5% | 24 | 77.4% | 7 | 22.6% | (9.6%, 41.1%) |
African American/Black | 14 | 3.0% | 13 | 92.9% | 1 | 7.1% | (0.2%, 33.9%) |
Asian | 87 | 18.4% | 68 | 78.2% | 19 | 21.8% | (13.7%, 32.0%) |
Others/unknown | 3 | 0.6% | 3 | 100.0% | 0 | 0.0% | N/A |
Had a PCR test—no. (%) | 65 | 13.7% | 48 | 73.8% | 17 | 26.2% | (16.0%, 38.5%) |
# Days from first PCR test to antibody test (must have occurred before the antibody test)—median, IQR | 15 | [11, 22] | 14 | [9, 20] | 17 | [13.0, 24.0] | N/A |
Symptom groups—no. (%) | |||||||
Asymptomatic since 15 February 2020 | 244 | 51.5% | 214 | 87.7% | 30 | 12.3% | (8.5%, 17.2%) |
Symptomatic, but no +PCR test prior to our AB samples | 217 | 45.8% | 178 | 82.0% | 39 | 18.0% | (13.1%, 23.7%) |
PCR+ test prior to our AB samples | 13 | 2.7% | 2 | 15.4% | 11 | 84.6% | (54.6%, 98.1%) |
# Days from symptom onset to first Ab test (n = 230) —median (IQR) | 25.5 | [17.0, 38.0] | 24 | [15.5, 39.0] | 29.5 | [21.0, 38.0] | N/A |
Binomial exact 95% confidence intervals for proportions of positive antibodies are located in the right-most column of the table. Percentages for the total health care workers are presented as a proportion of the total (column), whereas percentages for the antibody groups are presented as proportions of the subgroup (row) Std standard deviation, PCR Polymerase chain reaction, IQR Interquartile range, Ab test Chembio COVID-19 antibody test